Table 3 |
|||
|
Demographic data for ankylosing spondylitis patients stratified by fecal calprotectin positivity |
|||
|
Fecal calprotectin cutoff 50 μg/g |
|||
|
|
|||
|
Fecal calprotectin positive (n = 16) |
Fecal calprotectin negative (n = 23) |
P value |
|
|
|
|||
|
Mean age (years) |
45 |
49 |
0.48 |
|
Male, n (%) |
14 (88) |
18 (78) |
0.68 |
|
HLA-B27-positive, n (%) |
11 (69) |
18 (82) |
0.71 |
|
Mean disease duration (years) |
22 |
22 |
0.96 |
|
Ethnicity (%) |
|||
|
Caucasian |
8 |
74 |
0.71 |
|
Asian |
0 |
13 |
0.26 |
|
Hispanic |
19 |
13 |
0.67 |
|
|
|||
|
Matzkies et al. Arthritis Research & Therapy 2012 14:R261 doi:10.1186/ar4106 |
|||
